Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

Clinical trial NCT00073125 · COMPLETED

Trial details

NCT number: NCT00073125
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2003-05-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.